| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A useful add-on international prognostic score for mastocytosis?
|
Barete, Stéphane
|
|
|
6 |
12 |
p. e604-e605
|
article
|
| 2 |
Blood products: unmet needs for essential medicines
|
Burnouf, Thierry
|
|
|
6 |
12 |
p. e598-e599
|
article
|
| 3 |
Essential medicines: a balancing act
|
The Lancet Haematology,
|
|
|
6 |
12 |
p. e597
|
article
|
| 4 |
Frontline therapy in multiple myeloma: fast start for a long game
|
Patriarca, Francesca
|
|
|
6 |
12 |
p. e600-e601
|
article
|
| 5 |
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study
|
Sperr, Wolfgang R
|
|
|
6 |
12 |
p. e638-e649
|
article
|
| 6 |
Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial
|
Jackson, Graham H
|
|
|
6 |
12 |
p. e616-e629
|
article
|
| 7 |
Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial
|
Ahmed, Asra
|
|
|
6 |
12 |
p. e630-e637
|
article
|
| 8 |
Targeting the inflammatory cascade in haemophagocytic lymphohistiocytosis
|
Nikiforow, Sarah
|
|
|
6 |
12 |
p. e602-e603
|
article
|
| 9 |
The global need and availability of blood products: a modelling study
|
Roberts, Nicholas
|
|
|
6 |
12 |
p. e606-e615
|
article
|
Journal description